Investigation of simple BODIPY dyes as G-quadruplex recognizing ligands.
Żubertowski J, Rapp M, Dolicher J, Rubiś B, Dembska A.
RSC Adv. 2025 Feb 17;15(7):5220-5231. doi: 10.1039/d4ra08464k
Evaluation of reference genes for qPCR in human liver and kidney tissue from individuals with obesity.
Romaniuk-Drapała A, Kosicka-Noworzyń K, Sheng YH, Yohn C, Brunetti L, Kagan L.
Sci Rep. 2025 Feb 13;15(1):5347. doi: 10.1038/s41598-025-87911-x
Pharmacological Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) with Pentoxifylline and Tocopherol.
Słowik Ł, Totoń E, Nowak A, Wysocka-Słowik A, Okła M, Ślebioda Z.
J Clin Med. 2025 Feb 3;14(3):974. doi: 10.3390/jcm14030974
Fecal microbiota transplant from long-living Ames dwarf mice alters the microbial composition and biomarkers of liver health in normal mice.
Ashiqueali SA , Hayslip N, Chaudhari DS, Schneider A, Zhu X, Rubis B, Seavey CE, Alam MT, Hussein R, Noureddine SA, Golusinska-Kardach E, Pazdrowski P, Yadav H, Masternak MM.
Geroscience 2025. doi: 10.1007/s11357-025-01539-3
Obesity-related drug transporter expression alterations in human liver and kidneys.
Kosicka-Noworzyń K, Romaniuk-Drapała A, Sheng YH, Yohn C, Brunetti L, Kagan L.
Pharmacol Rep. 2024 Dec;76(6):1429-1442. doi: 10.1007/s43440-024-00665-7
Evaluation of Cytotoxic Activity of Cell Biomass from Eryngium planum and Lychnis flos-cuculi on Melanoma Cancer Cell.
Hermosaningtyas AA, Totoń E, Lisiak N, Kruszka D, Budzianowska A, Kikowska M.
Molecules. 2024 Oct 31;29(21):5158. doi: 10.3390/molecules29215158
Smartphone App-Based Remote Monitoring Challenges in Patients with Cardiac Resynchronization Therapy Defibrillators-A Multicenter Study.
Kowal D, Prech M, Katarzyńska-Szymańska A, Baszko A, Skonieczny G, Wabich E, Kempa M, Rubiś B, Mitkowski P.
J Clin Med. 2024 Oct 23;13(21):6323. doi: 10.3390/jcm13216323
Synergistic antitumor effect of liposomal-based formulations of olaparib and topotecan in primary epithelial ovarian cancer cells.
Romaniuk-Drapala A, Skupin-Mrugalska P, Garbuzenko O, Hatefi A, Minko T.
Cancer Cell Int. 2024 Aug 12;24(1):285. doi: 10.1186/s12935-024-03469-0
Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies.
Romaniuk-Drapała A, Totoń E, Taube M, Idzik M, Rubiś B, Lisiak N.
Cancers (Basel). 2024 Jul 7;16(13):2481. doi: 10.3390/cancers16132481
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells.
Kucinska M, Pospieszna J, Tang J, Lisiak N, Toton E, Rubis B, Murias M.
Biomed Pharmacother. 2024 Jul;176:116892. doi: 10.1016/j.biopha.2024.116892
Alternative Therapies in Transplantology as a Promising Perspective in Medicine.
Michalska N, Totoń E, Kopczyński P, Jankowska-Wajda M, Rubiś B.
Ann Transplant. 2024 Jun 4;29:e943387. doi: 10.12659/AOT.943387
Human Vault RNAs: Exploring Their Potential Role in Cellular Metabolism.
Taube M, Lisiak N, Totoń E, Rubiś B.
Int J Mol Sci. 2024 Apr 6;25(7):4072. doi: 10.3390/ijms25074072.
Pacemaker remote monitoring challenges in pediatric population: Single center long term experience.
Kowal D, Baszko A, Czyż K, Bobkowski W, Mitkowski P, Rubiś B.
Kardiol Pol. 2024;82(3):308-314. doi: 10.33963/v.phj.99761
Fisetin modulates the gut microbiota alongside biomarkers of senescence and inflammation in a DSS-induced murine model of colitis.
Ashiqueali SA, Chaudhari D, Zhu X, Noureddine S, Siddiqi S, Garcia DN, Gostynska A, Stawny M, Rubis B, Zanini BM, Mansoor MAM, Schneider A, Naser SA, Yadav H, Masternak MM.
Geroscience. 2024 Jun;46(3):3085-3103. doi: 10.1007/s11357-024-01060-z
Cytotoxic effects of kinetin riboside and its selected analogues on cancer cell lines.
Totoń E, Lisiak N, Romaniuk-Drapała A, Framski G, Wyszko E, Ostrowski T.
Bioorg Med Chem Lett. 2024 Mar 1;100:129628. doi: 10.1016/j.bmcl.2024.129628
miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy.
Dziechciowska I, Dąbrowska M, Mizielska A, Pyra N, Lisiak N, Kopczyński P, Jankowska-Wajda M, Rubiś B.
Curr Issues Mol Biol. 2023 Nov 25;45(12):9500-9525. doi: 10.3390/cimb45120595
The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review.
Derwich A, Sykutera M, Bromińska B, Rubiś B, Ruchała M, Sawicka-Gutaj N.
Int J Mol Sci. 2023 Jun 30;24(13):10952. doi: 10.3390/ijms241310952
Synthesis, Cytotoxicity and Molecular Docking of New Hybrid Compounds by Combination of Curcumin with Oleanolic Acid.
Sowa-Kasprzak K, Totoń E, Kujawski J, Olender D, Lisiak N, Zaprutko L, Rubiś B, Kaczmarek M, Pawełczyk A.
Biomedicines. 2023 May 23;11(6):1506. doi: 10.3390/biomedicines11061506
Cellular senescence in skin-related research: Targeted signaling pathways and naturally occurring therapeutic agents.
Dańczak-Pazdrowska A, Gornowicz-Porowska J, Polańska A, Krajka-Kuźniak V, Stawny M, Gostyńska A, Rubiś B, Nourredine S, Ashiqueali S, Schneider A, Tchkonia T, Wyles SP, Kirkland JL, Masternak MM.
Aging Cell. 2023 Jun;22(6):e13845. doi: 10.1111/acel.13845.
Cytotoxic Effect of Phenylethanoid Glycosides Isolated from Plantago lanceolata L.
Budzianowska A, Toton E, Romaniuk-Drapała A, Kikowska M, Budzianowski J.
Life 2023, Vol. 13, nr 2, art. 556: 1-13. doi: 10.3390/life13020556
Rosmarinic acid 4′-O-β-glucoside – A compound with prospective medicinal and cosmetological applications - its isolation from callus and root cultures of Eryngium species and biological activity.
Budzianowski J, Romaniuk-Drapała A, Kikowska M, Budzianowska A, Thiem B, Lisiak N, Rubiś B, Jacczak B, Kosmalska I, Totoń E.
Industrial Crops & Products 2023, Vol. 193, art. 116138: 1-11. doi: 10.1016/j.indcrop.2022.116138
Biological Activity of Oleanolic Acid Derivatives HIMOXOL and Br-HIMOLID in Breast Cancer Cells Is Mediated by ER and EGFR.
Lisiak N, Dzikowska P, Wisniewska U, Kaczmarek M, Bednarczyk-Cwynar B, Zaprutko L, Rubis B.
Int J Mol Sci. 2023 Mar 7;24(6):5099. doi: 10.3390/ijms24065099
Doxorubicin and cisplatin modulate miR-21, miR-106, miR-126, miR-155 and miR-199 levels in MCF7, MDA-MB-231 and SK-BR-3 cells that makes them potential elements of the DNA-damaging drug treatment response monitoring in breast cancer cells - a preliminary study.
Mizielska A, Dziechciowska I, Szczepański R, Cisek M, Dąbrowska M, Slężak J, Kosmalska I, Rymarczyk M, Wilkowska K, Jacczak B, Toton E , Lisiak N, Kopczyński P, Rubiś B.
Genes (Basel) 2023 : Vol. 14, nr 3, art. 702: 1-17. doi: 10.3390/genes14030702
Early Smartphone App-Based Remote Diagnosis of Silent Atrial Fibrillation and Ventricular Fibrillation in a Patient with Cardiac Resynchronization Therapy Defibrillator.
Kowal D, Katarzyńska-Szymańska A, Prech M, Rubiś B, Mitkowski P.
J Cardiovasc Dev Dis. 2023 Jan 14;10(1):30. doi: 10.3390/jcdd10010030
Opieka stomatologiczna nad pacjentem z grupy ryzyka martwicy kości szczęk w gabinecie stomatologicznym.
Słowik Ł, Nowak A, Okła M, Ślebioda Z, Osmola K, Totoń E.
Nowa Stomatol 2022;27(3):94-100. doi: 10.25121/NS.2022.27.3.94
Temozolomide efficacy in the adjuvant therapy of glioblastoma multiforme.
Totoń E, Romaniuk-Drapała A, Lisiak N, Świderska J, Rubiś B.
Farmacja Wspólczesna 2022; 15: 212-219. doi: 10.53139/FW.20221525
The Role of Telomerase in Breast Cancer’s Response to Therapy.
Judasz E, Lisiak N, Kopczyński P, Taube M, Rubiś B.
Int. J. Mol. Sci. 2022; 23, 12844. doi: 10.3390/ijms232112844
No Association between ABCB1 G2677T/A or C3435T Polymorphisms and Survival of Breast Cancer Patients—A 10-Year Follow-Up Study in the Polish Population.
Totoń E., Jacczak B., Barczak W., Jagielski P., Gryczka R., Hołysz H., Grodecka-Gazdecka S., Rubiś B.
Genes (Basel). 2022 Apr 21;13(5):729. doi: 10.3390/genes13050729
Proapoptotic and proautophagic activity of 20-hydroxyecdysone in breast cancer cells in vitro.
Romaniuk-Drapała A, Lisiak N, Totoń E, Matysiak A, Nawrot J, Nowak G, Kaczmarek M, Rybczyńska M, Rubiś B.
Chem. Biol. Interact. 2021; Vol. 342:109479. doi: 10.1016/j.cbi.2021.109479
Anti-SARS-CoV-2 strategies and the potential role of miRNA in the assessment of COVID-19 morbidity, recurrence, and therapy.
Narożna M, Rubiś B.
Int. J. Mol. Sci. 2021; 22, 8663. doi: 10.3390/ijms22168663
Anti-leukemia activity of Au/CuO/ZnO nanoparticles synthesized used Verbena officinalis extract.
Dobrucka R, Romaniuk-Drapała A, Kaczmarek M.
J Inorg Organomet Polym 2021; 31, 191–202. doi: 10.1007/s10904-020-01690-8
LEP (-2548G>A LEP) and LEPR (223Gln>Arg, 109Lys>Arg) polymorphisms as breast cancer risk factors in the Polish female population.
Hołysz H, Paszel-Jaworska A, Romaniuk-Drapała A, Grodecka-Gazdecka S, Rubiś B.
Mol. Biol. Rep. 2021; 1-8. doi: 10.1007/s11033-021-06328-7
hTERT downregulation attenuates resistance to DOX, impairs FAK - mediated adhesion, and leads to autophagy induction in breast cancer cells.
Romaniuk-Drapała A, Totoń E, Konieczna N, Machnik M, Barczak W, Kowal D, Kopczyński P, Kaczmarek M, Rubiś B.
Cells 2021; Vol. 10, nr 4: 867. doi: 10.3390/cells10040867
Facile synthesis of Au/ZnO/Ag nanoparticles using Glechoma hederacea L. extract, and their activity against leukemia.
Dobrucka R, Romaniuk-Drapała A, Kaczmarek M.
Biomed Microdevices 23, 14 (2021). doi: 10.1007/s10544-021-00557-0
Addition of popular exogenous antioxidant agent, PBN, to culture media may be an important step to optimization of myogenic stem/progenitor cell preparation protocol.
Nowaczyk M, Malcher A, Zimna A, Łabędź W, Kubaszewski Ł, Barczak W, Rubiś B, Rozwadowska N, Kurpisz M.
Antioxidants. 2021; 10(6):959. doi: 10.3390/antiox10060959
Potential of naturally derived compounds in telomerase and telomere modulation in skin senescence and aging.
Jacczak B, Rubiś B, Totoń E.
Int. J. Mol. Sci. 2021; 22, 6381. doi: 10.3390/ijms22126381
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Lisiak N.
Autophagy 2021; Vol. 17 (1): 1-382, doi: 10.1080/15548627.2020.1797280
Cytotoxic, analgesic and anti-inflammatory activity of colchicine and its C-10 sulfur containing derivatives.
Kurek J, Myszkowski K, Okulicz-Kozaryn I, Kurant A, Kamińska E, Szulc M, Rubiś B, Kaczmarek M, Mikołajczak P, Murias M.
Sci Rep 2021; 11, 9034. doi: 10.1038/s41598-021-88260-1
Zastosowanie leptyny rekombinowanej w leczeniu różnych typów lipodystrofii.
Hołysz H, Totoń E.
Post. Hig. Med. Dośw. 2021; Vol. 75, 815-822. doi: 10.2478/ahem-2021-0016
Contribution of Dopamine Transporter Gene Methylation Status to Cannabis Dependency.
Grzywacz A, Barczak W, Chmielowiec J, Chmielowiec K, Suchanecka A, Trybek G, Masiak J, Jagielski P, Grocholewicz K, Rubiś B.
Brain Sci. 2020 Jun 23;10(6):400. doi: 10.3390/brainsci10060400
Biologically synthesized of Au/Pt/ZnO nanoparticles using Arctium lappa extract and cytotoxic activity against leukemia.
Dobrucka R, Romaniuk-Drapała A, Kaczmarek M.
Biomed Microdevices 22, 72 (2020). doi: 10.1007/s10544-020-00526-z
Telomere length: how the length makes a difference.
Lulkiewicz M, Bajsert J, Kopczyński P, Barczak W, Rubiś B.
Mol. Biol. Rep. 2020 : Vol. 47, nr 9, s. 7181-7188. doi: 10.1007/s11033-020-05551-y
Mucoadhesive chitosan delivery system with Chelidonii Herba lyophilized extract as a promising strategy for vaginitis treatment.
Paczkowska M, Chanaj-Kaczmarek J, Romaniuk-Drapała A, Rubiś B, Szymanowska D, Kobus-Cisowska J, Szymańska E, Winnicka K, Cielecka-Piontek J.
J. Clin. Med. 2020 : Vol. 9, nr 4, art. 1208:1-9. doi: 10.3390/jcm9041208
Genetic Editing and Pharmacogenetics in Current and Future Therapy of Neurocognitive Disorders.
Prendecki M, Kowalska M, Toton E, Kozubski W.
Current Alzheimer Research 2020, 17, 238-258. doi: 10.2174/1567205017666200422152440
Totoń E, Kędziora I, Romaniuk-Drapała A, Konieczna N, Kaczmarek M, Lisiak N, Paszel-Jaworska A, Rybska A, Duszyńska W, Budzianowski J, Rybczyńska M, Rubiś B.
Pharm. Rep. 2020 January, pp 1-13. doi: 10.1007/s43440-019-00008-x
Mammaglobin A as a diagnostic marker and therapeutic target in breast cancer.
Lisiak N, Sierszulska M, Bajsert J.
Post. Hig. Med. Dośw. 2020, 74: 566-571. doi: 10.5604/01.3001.0014.5782
Evaluation of biological synthesized platinum nanoparticles using Ononidis radix extract on the cell lung carcinoma A549.
Dobrucka R, Romaniuk-Drapała A, Kaczmarek M.
Biomed Microdevices 21, 75 (2019). doi: 10.1007/s10544-019-0424-7
Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-CancerCells MCF7 and MDA-MB-231.
Konieczna N, Romaniuk-Drapała A, Lisiak N, Totoń E, Paszel-Jaworska A, Kaczmarek M, Rubiś B.
Int J Mol Sci. 2019 May 30; 20(11). pii: E2670. doi: 10.3390/ijms20112670
Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin.
Rubis B, Luczak MW, Krawic C, Zhitkovich A.
Free Radic Biol Med. 2019 May 20;136:12-21. doi: 10.1016/j.freeradbiomed.2019.03.026. Epub 2019 Mar 26.
Vitamin C as a Modulator of the Response to Cancer Therapy.
Blaszczak W, Barczak W, Masternak J, Kopczyński P, Zhitkovich A, Rubiś B.
Molecules. 2019 Jan 28;24(3). pii: E453. doi: 10.3390/molecules24030453
The non-canonical functions of telomerase: to turn off or not to turn off.
Romaniuk A, Paszel-Jaworska A, Totoń E, Lisiak N, Hołysz H, Królak A, Grodecka-Gazdecka S, Rubiś B.
Mol Biol Rep. 2019 Feb;46(1):1401-1411. doi: 10.1007/s11033-018-4496-x
Binding Study of the Fluorescent Carbazole Derivative with Human Telomeric G-Quadruplexes.
Głuszyńska A, Juskowiak B, Rubiś B.
Molecules. 2018 Nov 30;23(12). pii: E3154. doi: 10.3390/molecules23123154
Kaczmarek M, Rubis B, Frydrychowicz M, Nowicka A, Brajer-Luftmann B, Kozlowska M, Lagiedo M, Batura-Gabryel H, Sikora J.
Cancer Invest. 2018;36(5):264-278. doi: 10.1080/07357907.2018.1477158. Epub 2018 Jul 23.
hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression.
Sobecka A, Blaszczak W, Barczak W, Golusinski P, Rubis B, Masternak MM, Suchorska WM, Golusinski W.
J Appl Genet. 2018 Aug 7. doi: 10.1007/s13353-018-0458-1
Serum from patients with chronic obstructive pulmonary disease induces senescence-related phenotype in bronchial epithelial cells.
Kuźnar-Kamińska B, Mikuła-Pietrasik J, Witucka A, Romaniuk A, Konieczna N, Rubiś B, Książek K, Tykarski A, Batura-Gabryel H.
Sci Rep. 2018 Aug 28;8(1):12940. doi: 10.1038/s41598-018-31037
Pleural Macrophages can Promote or Inhibit Apoptosis of Malignant Cells via Humoral Mediators Depending on Intracellular Signaling Pathways.
Kaczmarek M, Rubis B, Frydrychowicz M, Nowicka A, Brajer-Luftmann B, Kozlowska M, Lagiedo M, Batura-Gabryel H, Sikora J.
Cancer Invest. 2018; 36(5): 264-278. doi: 10.1080/07357907.2018.1477158
hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification.
Barczak W, Sobecka A, Golusinski P, Masternak MM, Rubiś B, Suchorska WM, Golusinski W.
Sci Rep. 2018 Apr 13;8(1):5949. doi: 10.1038/s41598-018-24503-y
Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment.
Lisiak N, Toton E, Rybczynska M.
Curr Cancer Drug Targets. 2017 Nov 14. doi: 10.2174/1568009617666171114143330
Impact of PKCε downregulation on autophagy in glioblastoma cells.
Totoń E, Romaniuk A, Konieczna N, Hofmann J, Barciszewski J, Rybczyńska M.
BMC Cancer 2018: Vol. 18; 185: 1-17. doi: 10.1186/s12885-018-4095-1
Telomerase and drug resistance in cancer.
Lipińska N, Romaniuk A, Paszel-Jaworska A, Toton E, Kopczynski P, Rubis B.
Cell Mol Life Sci. 2017: Vol. 74: 4121-4132. doi: 10.1007/s00018-017-2573-2
hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer.
Barczak W, Suchorska W, Sobecka A, Bednarowicz K, Machczyński P, Golusiński P, Rubiś B, Masternak MM, Golusiński W.
Mol. Med. Rep. 2017: Vol. 16, nr 1, s. 441-446. doi: 10.3892/mmr.2017.6590
Nanoscale size effect in in situ titanium based composites with cell viability and cytocompatibility studies.
Miklaszewski A, Jurczyk MU, Kaczmarek M, Paszel-Jaworska A, Romaniuk A, Lipińska N, Żurawski J, Urbaniak P, Jurczyk M.
Mater. Sci. Eng. C Mater. Biol. Appl. 2017: Vol. 73, s. 525-536. doi: 10.1016/j.msec.2016.12.100
Semisynthetic oleanane triterpenoids inhibit migration and invasion of human breast cancer cells through downregulated expression of the ITGB1/PTK2/PXN pathway.
Lisiak N, Paszel-Jaworska A, Totoń E, Rubiś B, Pakuła M, Bednarczyk-Cwynar B, Zaprutko L, Rybczyńska M.
Chem. Biol. Interact. 2017: Vol. 268, s. 136-147. doi: 10.1016/j.cbi.2017.03.008
Strain-dependent mutational effects for Pepino mosaic virus in a natural host.
Minicka J, Elena SF, Borodynko-Filas N, Rubiś B, Hasiów-Jaroszewska B.
BMC Evol. Biol. 2017: Vol. 17, nr 1, art. 67, s. 1-11. doi: 10.1186/s12862-017-0920-4
Effect of growth differentiation factor-9 C447T and G546A polymorphisms on the outcomes of in vitro fertilization.
Serdyńska-Szuster M, Jędrzejczak P, Ożegowska KE, Hołysz H, Pawelczyk L, Jagodziński PP.
Mol. Med. Rep. 2016: Vol. 13, nr 5, s. 4437-4442. doi: 10.3892/mmr.2016.5060
Formaldehyde is a potent proteotoxic stressor causing rapid heat shock transcription factor 1 activation and Lys48-linked polyubiquitination of proteins.
Ortega-Atienza S, Rubiś B, McCarthy C, Zhitkovich A.
Am. J. Pathol. 2016: Vol. 186, nr 11, s. 2857-2868. doi: 10.1016/j.ajpath.2016.06.022
In vitro biocompatibility of anodized titanium with deposited silver nanodendrites.
Kaczmarek M, Jurczyk K, Koper JK, Paszel-Jaworska A, Romaniuk A, Lipińska N, Żurawski J, Urbaniak P, Jakubowicz J, Jurczyk MU.
J. Mater. Sci. 2016: Vol. 51, nr 11, s. 5259-5270. doi: 10.1007/s10853-016-9829-3
In vitro biocompatibility of titanium after plasma surface alloying with boron.
Kaczmarek M, Jurczyk MU, Miklaszewski A, Paszel-Jaworska A, Romaniuk A, Lipińska N, Żurawski J, Urbaniak P, Jurczyk K.
Mater. Sci. Eng. C Mater. Biol. Appl. 2016: Vol. 69, s. 1240-1247. doi: 10.1016/j.msec.2016.08.006
Increased proapoptotic activity of electron beam irradiated doxorubicin and epirubicin in multidrug-resistant human leukemic cells.
Paszel-Jaworska A, Totoń E, Dettlaff K, Kaczmarek A, Bednarski W, Oszczapowicz I, Jelińska A, Rybczyńska M.
Chem. Biol. Interact. 2016: Vol. 258, s. 69-78. doi: 10.1016/j.cbi.2016.08.011
Novel promising estrogenic receptor modulators: cytotoxic and estrogenic activity of benzanilides and dithiobenzanilides.
Kucińska M, Giron MD, Piotrowska H, Lisiak N, Granig WH, Lopez-Jaramillo FJ, Salto R, Murias M, Erker T.
PLoS ONE 2016: Vol. 11, nr 1, e0145615, s. 1-16. doi: 10.1371/journal.pone.0145615
Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells.
Kucińska M, Piotrowska-Kempisty H, Lisiak N. Kaczmarek M, Dams-Kozłowska H, Granig WH, Höferl M, Jäger W, Zehl M, Murias M, Erker T.
Toxicol. In Vitro 2016: Vol. 37, s. 148-161. doi: 10.1016/j.tiv.2016.09.017
Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer.
Barczak W, Rozwadowska N, Romaniuk A, Lipińska N, Lisiak N, Grodecka-Gazdecka S, Książek K, Rubiś B.
Oncol. Lett. 2016: Vol. 11, nr 3, s. 2305-2309. doi: 10.3892/ol.2016.4188
The synthetic oleanane triterpenoid HIMOXOL induces autophagy in breast cancer cells via ERK1/2 MAPK pathway and Beclin-1 up-regulation.
Lisiak N, Totoń E, Rubiś B, Majer B, Rybczyńska M.
Anticancer Agents Med. Chem. 2016: Vol. 16, nr 8, s. 1066-1076. doi: 10.2174/1871520616666160223114104
Zapotin (5,6,2',6'-tetramethoxyflavone) modulates the crosstalk between autophagy and apoptosis pathways in cancer cells with overexpressed constitutively active PKC.
Totoń E, Romaniuk A, Budzianowski J, Hofmann J, Rybczyńska M.
Nutr. Cancer 2016: Vol. 68, nr 2, s. 290-304. doi: 10.1080/01635581.2016.1134595
DAT1 methylation changes in alcohol-dependent individuals vs. controls.
Jasiewicz A, Rubiś B, Samochowiec J, Małecka I, Suchanecka A, Jabłoński M, Grzywacz A.
J. Psychiatr. Res. 2015: Vol. 64, s. 130-133. doi: 10.1016/j.jpsychires.2015.03.007
Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites.
Karaźniewicz-Łada M, Danielak D, Rubiś B, Burchardt P, Komosa A, Lesiak M, Główka F.
J. Clin. Pharm. Ther. 2015: Vol. 40, nr 2, s. 226-231. doi: 10.1111/jcpt.12236
Proapoptotic activity and ABCC1-related multidrug resistance reduction ability of semisynthetic oleanolic acid derivatives DIOXOL and HIMOXOL in human acute promyelocytic leukemia cells.
Paszel-Jaworska A, Rubiś B, Bednarczyk-Cwynar B, Zaprutko L, Rybczyńska M.
Chem. Biol. Interact. 2015: Vol. 242, s. 1-12. doi: 10.1016/j.cbi.2015.07.011
Telomere shortening in Down syndrome patients - when does it start?
Gruszeczka A, Kopczyński P, Cudziło D, Lipińska N, Romaniuk A, Barczak W, Rozwadowska N, Totoń E, Rubiś B.
DNA Cell Biol. 2015: Vol. 34, nr 6, s. 412-417. doi: 10.1089/dna.2014.2746
Universal real-time PCR-based assay for lentiviral titration.
Barczak W, Suchorska W, Rubiś B, Kulcenty K.
Mol. Biotechnol. 2015: Vol. 57, nr 2, s. 195-200. doi: 10.1007/s12033-014-9815-4
Autofagia, nowe perspektywy w terapii przeciwnowotworowej.
Lisiak N, Totoń E, Rybczyńska M.
Post. Hig. Med. Dośw. 2014: T. 68, s. 925-935. doi: 10.5604/17322693.1111361
Beclin-1 and its role as a target for anticancer therapy.
Totoń E, Lisiak N, Sawicka P, Rybczyńska M.
J. Physiol. Pharmacol. 2014: Vol. 65, nr 4, s. 459-467.
In vitro biocompatibility of Ti-45S5 bioglass nanocomposites and their scaffolds.
Kaczmarek M, Jurczyk MU, Rubiś B, Banaszak A, Kolecka A, Paszel A, Jurczyk K, Murias M, Sikora J, Jurczyk M.
J. Biomed. Mater. Res. A 2014: Vol. 102A, nr 5, s. 1316-1324. doi: 10.1002/jbm.a.34808
Methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate (MIXOMOL), a synthetic oleanolic acid derivative, induces both apoptosis and autophagy in MDA-MB-231 breast cancer cells.
Lisiak N, Paszel-Jaworska A, Bednarczyk-Cwynar B, Zaprutko L, Kaczmarek M, Rybczyńska M.
Chem. Biol. Interact. 2014: Vol. 208, s. 47-57. doi: 10.1016/j.cbi.2013.11.009
Molecular mechanisms of biological activity of oleanolic acid - a source of inspiration for a new drugs design.
Paszel-Jaworska A, Romaniuk A, Rybczyńska M.
Mini Rev. Org. Chem. 2014: Vol. 11, nr 3, s. 330-342. doi:10.2174/1570193X1103140915111839
Telomerase modulation in therapeutic approach.
Romaniuk A, Kopczyński P, Książek K, Rubiś B.
Curr. Pharm. Des. 2014: Vol. 20, nr 41, s. 6438-6451. doi: 10.2174/1381612820666140630092721
The influence of genetic polymorphism of Cyp2c19 isoenzyme on the pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.
Karaźniewicz-Łada M, Danielak D, Rubiś B, Burchardt P, Oszkinis G, Główka F.
J. Clin. Pharmacol. 2014: Vol. 54, nr 8, s. 874-880. doi: 10.1002/jcph.323